Følg
Mikkel Z Oestergaard
Mikkel Z Oestergaard
Merck / MSD
Bekræftet mail på merck.com
Titel
Citeret af
Citeret af
År
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
H Blencowe, S Cousens, MZ Oestergaard, D Chou, AB Moller, R Narwal, ...
The Lancet 379 (9832), 2162-2172, 2012
52002012
Born too soon: the global epidemiology of 15 million preterm births
H Blencowe, S Cousens, D Chou, M Oestergaard, L Say, AB Moller, ...
Reproductive health 10 (1), 1-14, 2013
22592013
Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities
MZ Oestergaard, M Inoue, S Yoshida, WR Mahanani, FM Gore, ...
PLoS Med 8 (8), e1001080, 2011
6042011
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology, 2017
3432017
Cancer genetics of epigenetic genes
A Miremadi, MZ Oestergaard, PDP Pharoah, C Caldas
Human molecular genetics 16 (R1), R28-R49, 2007
3012007
Newborn survival: a multi-country analysis of a decade of change
JE Lawn, MV Kinney, RE Black, C Pitt, S Cousens, K Kerber, E Corbett, ...
Health policy and planning 27 (suppl_3), iii6-iii28, 2012
2632012
Child mortality estimation: accelerated progress in reducing global child mortality, 1990–2010
K Hill, D You, M Inoue, MZ Oestergaard
PLoS Med 9 (8), e1001303, 2012
1552012
A new method for deriving global estimates of maternal mortality
JR Wilmoth, N Mizoguchi, MZ Oestergaard, L Say, CD Mathers, ...
Statistics, Politics, and Policy 3 (2), 2012
1052012
The role of a bioresource research impact factor as an incentive to share human bioresources
A Cambon-Thomsen, GA Thorisson, L Mabile
Nature genetics 43 (6), 503, 2011
882011
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
M Klanova, LH Sehn, I Bence-Bruckler, F Cavallo, J Jin, M Martelli, ...
blood 133 (9), 919-926, 2019
842019
Common variants in mismatch repair genes and risk of colorectal cancer
T Koessler, MZ Oestergaard, H Song, J Tyrer, B Perkins, AM Dunning, ...
Gut 57 (8), 1097-1101, 2008
692008
South African child deaths 1990–2011: have HIV services reversed the trend enough to meet Millennium Development Goal 4?
KJ Kerber, JE Lawn, LF Johnson, M Mahy, RE Dorrington, H Phillips, ...
AIDS (London, England) 27 (16), 2637, 2013
552013
PD-L1 and tumor-associated macrophages in de novo DLBCL
R McCord, CR Bolen, H Koeppen, EE Kadel, MZ Oestergaard, T Nielsen, ...
Blood advances 3 (4), 531-540, 2019
542019
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA …
C Kurzeder, I Bover, F Marmé, J Rau, P Pautier, N Colombo, D Lorusso, ...
Journal of Clinical Oncology 34 (21), 2516-2525, 2016
532016
Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential …
V Jurinovic, V Passerini, MZ Oestergaard, A Knapp, K Mundt, S Araf, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
482019
Interactions between genes involved in the antioxidant defence system and breast cancer risk
MZ Oestergaard, J Tyrer, A Cebrian, M Shah, AM Dunning, BAJ Ponder, ...
British journal of cancer 95 (4), 525-531, 2006
442006
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Clinical Cancer Research 25 (15), 4634-4643, 2019
432019
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
CR Bolen, M Klanova, M Trneny, LH Sehn, J He, J Tong, JN Paulson, ...
haematologica 105 (9), 2020
252020
Prognostic impact of BCL2 and MYC expression and translocation in untreated DLBCL: results from the phase III GOYA study
LH Sehn, MZ Oestergaard, M Trněný, A Bosi, M Egyed, A Illes, ...
Hematological Oncology 35, 131-133, 2017
192017
An idea whose time has come ?An African foresight observatory on genomics medicine and data-intensive global science
C Dandara, C Adebamowo, J de Vries, E S Dove, E Fisher, R A Gibbs, ...
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2012
182012
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20